In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
<h4>Background</h4>Treatment failure and resistance to the commonly used drugs remains a major obstacle for successful chemotherapy against visceral leishmaniasis (VL). Since the development of novel therapeutics involves exorbitant costs, the effectiveness of the currently available ant...
Saved in:
Main Authors: | Supriya Khanra (Author), Subir Kumar Juin (Author), Junaid Jibran Jawed (Author), Sweta Ghosh (Author), Shreyasi Dutta (Author), Shaik Abdul Nabi (Author), Jyotirmayee Dash (Author), Dipak Dasgupta (Author), Subrata Majumdar (Author), Rahul Banerjee (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents
by: Ahmed H.E. Hassan, et al.
Published: (2023) -
Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers
by: Wu G, et al.
Published: (2023) -
HMM-based profiling identifies the binding to divalent cations and nucleotides as common denominators of suramin targets
by: Dennis A. Hauser, et al.
Published: (2023) -
Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes
by: Gabriela Chyła-Danił, et al.
Published: (2023) -
Suramin inhibits antibody binding to cell surface antigens and disrupts complement-mediated mesangial cell lysis
by: Honglan Piao, et al.
Published: (2016)